Cargando…
Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis
Background: Intraplaque hemorrhage (IPH) is a hallmark of atherosclerotic plaque instability. Biliverdin reductase B (BLVRB) is enriched in plasma and plaques from patients with symptomatic carotid atherosclerosis and functionally associated with IPH. Objective: We explored the biomarker potential o...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296390/ https://www.ncbi.nlm.nih.gov/pubmed/37371462 http://dx.doi.org/10.3390/biom13060882 |
_version_ | 1785063647054135296 |
---|---|
author | Chemaly, Melody Marlevi, David Iglesias, Maria-Jesus Lengquist, Mariette Kronqvist, Malin Bos, Daniel van Dam-Nolen, Dianne H. K. van der Kolk, Anja Hendrikse, Jeroen Kassem, Mohamed Matic, Ljubica Odeberg, Jacob de Vries, Margreet R. Kooi, M. Eline Hedin, Ulf |
author_facet | Chemaly, Melody Marlevi, David Iglesias, Maria-Jesus Lengquist, Mariette Kronqvist, Malin Bos, Daniel van Dam-Nolen, Dianne H. K. van der Kolk, Anja Hendrikse, Jeroen Kassem, Mohamed Matic, Ljubica Odeberg, Jacob de Vries, Margreet R. Kooi, M. Eline Hedin, Ulf |
author_sort | Chemaly, Melody |
collection | PubMed |
description | Background: Intraplaque hemorrhage (IPH) is a hallmark of atherosclerotic plaque instability. Biliverdin reductase B (BLVRB) is enriched in plasma and plaques from patients with symptomatic carotid atherosclerosis and functionally associated with IPH. Objective: We explored the biomarker potential of plasma BLVRB through (1) its correlation with IPH in carotid plaques assessed by magnetic resonance imaging (MRI), and with recurrent ischemic stroke, and (2) its use for monitoring pharmacotherapy targeting IPH in a preclinical setting. Methods: Plasma BLVRB levels were measured in patients with symptomatic carotid atherosclerosis from the PARISK study (n = 177, 5 year follow-up) with and without IPH as indicated by MRI. Plasma BLVRB levels were also measured in a mouse vein graft model of IPH at baseline and following antiangiogenic therapy targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Results: Plasma BLVRB levels were significantly higher in patients with IPH (737.32 ± 693.21 vs. 520.94 ± 499.43 mean fluorescent intensity (MFI), p = 0.033), but had no association with baseline clinical and biological parameters. Plasma BLVRB levels were also significantly higher in patients who developed recurrent ischemic stroke (1099.34 ± 928.49 vs. 582.07 ± 545.34 MFI, HR = 1.600, CI [1.092–2.344]; p = 0.016). Plasma BLVRB levels were significantly reduced following prevention of IPH by anti-VEGFR-2 therapy in mouse vein grafts (1189 ± 258.73 vs. 1752 ± 366.84 MFI; p = 0.004). Conclusions: Plasma BLVRB was associated with IPH and increased risk of recurrent ischemic stroke in patients with symptomatic low- to moderate-grade carotid stenosis, indicating the capacity to monitor the efficacy of IPH-preventive pharmacotherapy in an animal model. Together, these results suggest the utility of plasma BLVRB as a biomarker for atherosclerotic plaque instability. |
format | Online Article Text |
id | pubmed-10296390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102963902023-06-28 Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis Chemaly, Melody Marlevi, David Iglesias, Maria-Jesus Lengquist, Mariette Kronqvist, Malin Bos, Daniel van Dam-Nolen, Dianne H. K. van der Kolk, Anja Hendrikse, Jeroen Kassem, Mohamed Matic, Ljubica Odeberg, Jacob de Vries, Margreet R. Kooi, M. Eline Hedin, Ulf Biomolecules Article Background: Intraplaque hemorrhage (IPH) is a hallmark of atherosclerotic plaque instability. Biliverdin reductase B (BLVRB) is enriched in plasma and plaques from patients with symptomatic carotid atherosclerosis and functionally associated with IPH. Objective: We explored the biomarker potential of plasma BLVRB through (1) its correlation with IPH in carotid plaques assessed by magnetic resonance imaging (MRI), and with recurrent ischemic stroke, and (2) its use for monitoring pharmacotherapy targeting IPH in a preclinical setting. Methods: Plasma BLVRB levels were measured in patients with symptomatic carotid atherosclerosis from the PARISK study (n = 177, 5 year follow-up) with and without IPH as indicated by MRI. Plasma BLVRB levels were also measured in a mouse vein graft model of IPH at baseline and following antiangiogenic therapy targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Results: Plasma BLVRB levels were significantly higher in patients with IPH (737.32 ± 693.21 vs. 520.94 ± 499.43 mean fluorescent intensity (MFI), p = 0.033), but had no association with baseline clinical and biological parameters. Plasma BLVRB levels were also significantly higher in patients who developed recurrent ischemic stroke (1099.34 ± 928.49 vs. 582.07 ± 545.34 MFI, HR = 1.600, CI [1.092–2.344]; p = 0.016). Plasma BLVRB levels were significantly reduced following prevention of IPH by anti-VEGFR-2 therapy in mouse vein grafts (1189 ± 258.73 vs. 1752 ± 366.84 MFI; p = 0.004). Conclusions: Plasma BLVRB was associated with IPH and increased risk of recurrent ischemic stroke in patients with symptomatic low- to moderate-grade carotid stenosis, indicating the capacity to monitor the efficacy of IPH-preventive pharmacotherapy in an animal model. Together, these results suggest the utility of plasma BLVRB as a biomarker for atherosclerotic plaque instability. MDPI 2023-05-24 /pmc/articles/PMC10296390/ /pubmed/37371462 http://dx.doi.org/10.3390/biom13060882 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chemaly, Melody Marlevi, David Iglesias, Maria-Jesus Lengquist, Mariette Kronqvist, Malin Bos, Daniel van Dam-Nolen, Dianne H. K. van der Kolk, Anja Hendrikse, Jeroen Kassem, Mohamed Matic, Ljubica Odeberg, Jacob de Vries, Margreet R. Kooi, M. Eline Hedin, Ulf Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis |
title | Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis |
title_full | Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis |
title_fullStr | Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis |
title_full_unstemmed | Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis |
title_short | Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis |
title_sort | biliverdin reductase b is a plasma biomarker for intraplaque hemorrhage and a predictor of ischemic stroke in patients with symptomatic carotid atherosclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296390/ https://www.ncbi.nlm.nih.gov/pubmed/37371462 http://dx.doi.org/10.3390/biom13060882 |
work_keys_str_mv | AT chemalymelody biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT marlevidavid biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT iglesiasmariajesus biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT lengquistmariette biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT kronqvistmalin biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT bosdaniel biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT vandamnolendiannehk biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT vanderkolkanja biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT hendriksejeroen biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT kassemmohamed biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT maticljubica biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT odebergjacob biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT devriesmargreetr biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT kooimeline biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis AT hedinulf biliverdinreductasebisaplasmabiomarkerforintraplaquehemorrhageandapredictorofischemicstrokeinpatientswithsymptomaticcarotidatherosclerosis |